BIOGEN INC. Increase (Decrease) in Income Taxes Payable
BIOGEN INC. (BIIB) reported Increase (Decrease) in Income Taxes Payable of $18.40 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable · last filed 2026-04-29
- BIOGEN INC. increase (decrease) in income taxes payable for the quarter ending 2026-03-31 was $18.40M, a 73.37% decline year-over-year.
- BIOGEN INC. increase (decrease) in income taxes payable for the quarter ending 2025-12-31 was -$194.00M, a 1282.93% decline year-over-year.
- BIOGEN INC. increase (decrease) in income taxes payable for the quarter ending 2025-09-30 was -$229.40M, a 428.65% decline year-over-year.
- BIOGEN INC. increase (decrease) in income taxes payable for the quarter ending 2025-06-30 was -$603.80M.
- BIOGEN INC. increase (decrease) in income taxes payable for fiscal 2025 was -$958.10M, a 1320.51% decline from fiscal 2024.
- BIOGEN INC. increase (decrease) in income taxes payable for fiscal 2024 was $78.50M.
- BIOGEN INC. increase (decrease) in income taxes payable for fiscal 2023 was -$299.00M.
- BIOGEN INC. increase (decrease) in income taxes payable for fiscal 2022 was -$142.30M, a 161.66% decline from fiscal 2021.
| Period end | Increase (Decrease) in Income Taxes Payable 3 month | Increase (Decrease) in Income Taxes Payable 3 month as first filed | Increase (Decrease) in Income Taxes Payable 6 month | Increase (Decrease) in Income Taxes Payable 6 month as first filed | Increase (Decrease) in Income Taxes Payable 9 month | Increase (Decrease) in Income Taxes Payable 12 month | Increase (Decrease) in Income Taxes Payable 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | $18.40M 10-Q · filed 2026-04-29 | -$175.60M derived: sum of 2 quarters · filed 2026-04-29 | -$405.00M derived: sum of 3 quarters · filed 2026-04-29 | -$1.01B derived: sum of 4 quarters · filed 2026-04-29 | |||
| 2025-12-31 | -$194.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | -$423.40M derived: sum of 2 quarters · filed 2026-02-06 | -$1.03B derived: sum of 3 quarters · filed 2026-02-06 | -$958.10M 10-K · filed 2026-02-06 | |||
| 2025-09-30 | -$229.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$833.20M derived: sum of 2 quarters · filed 2025-10-30 | -$764.10M 10-Q · filed 2025-10-30 | -$747.70M derived: sum of 4 quarters · filed 2026-04-29 | |||
| 2025-06-30 | -$603.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | -$534.70M 10-Q · filed 2025-07-31 | -$518.30M derived: sum of 3 quarters · filed 2026-04-29 | -$448.50M derived: sum of 4 quarters · filed 2026-04-29 | |||
| 2025-03-31 | $69.10M 10-Q · filed 2026-04-29 | $85.50M derived: sum of 2 quarters · filed 2026-04-29 | $155.30M derived: sum of 3 quarters · filed 2026-04-29 | $149.80M derived: sum of 4 quarters · filed 2026-04-29 | |||
| 2024-12-31 | $16.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $86.20M derived: sum of 2 quarters · filed 2026-02-06 | $80.70M derived: sum of 3 quarters · filed 2026-02-06 | $78.50M 10-K · filed 2026-02-06 | |||
| 2024-09-30 | $69.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $64.30M derived: sum of 2 quarters · filed 2025-10-30 | $62.10M 10-Q · filed 2025-10-30 | -$122.10M derived: sum of 4 quarters · filed 2026-02-06 | |||
| 2024-06-30 | -$5.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | -$7.70M 10-Q · filed 2025-07-31 | -$191.90M derived: sum of 3 quarters · filed 2026-02-06 | -$224.30M derived: sum of 4 quarters · filed 2026-02-06 | |||
| 2024-03-31 | -$2.20M 10-Q · filed 2025-05-01 | -$186.40M derived: sum of 2 quarters · filed 2026-02-06 | -$218.80M derived: sum of 3 quarters · filed 2026-02-06 | -$366.20M derived: sum of 4 quarters · filed 2026-02-06 | |||
| 2023-12-31 | -$184.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | -$216.60M derived: sum of 2 quarters · filed 2026-02-06 | -$364.00M derived: sum of 3 quarters · filed 2026-02-06 | -$299.00M 10-K · filed 2026-02-06 | |||
| 2023-09-30 | -$32.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | -$179.80M derived: sum of 2 quarters · filed 2024-10-30 | -$114.80M 10-Q · filed 2024-10-30 | -$156.90M derived: sum of 4 quarters · filed 2025-02-12 | |||
| 2023-06-30 | -$147.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$82.40M 10-Q · filed 2024-08-01 | -$124.50M derived: sum of 3 quarters · filed 2025-02-12 | -$158.80M derived: sum of 4 quarters · filed 2025-02-12 | |||
| 2023-03-31 | $65.00M 10-Q · filed 2024-04-24 | $22.90M derived: sum of 2 quarters · filed 2025-02-12 | -$11.40M derived: sum of 3 quarters · filed 2025-02-12 | -$179.20M derived: sum of 4 quarters · filed 2025-02-12 | |||
| 2022-12-31 | -$42.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | -$76.40M derived: sum of 2 quarters · filed 2025-02-12 | -$244.20M derived: sum of 3 quarters · filed 2025-02-12 | -$142.30M 10-K · filed 2025-02-12 | |||
| 2022-09-30 | -$34.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$202.10M derived: sum of 2 quarters · filed 2023-11-08 | -$100.20M 10-Q · filed 2023-11-08 | -$129.90M derived: sum of 4 quarters · filed 2024-02-14 | |||
| 2022-06-30 | -$167.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-25 | -$65.90M 10-Q · filed 2023-07-25 | -$95.60M derived: sum of 3 quarters · filed 2024-02-14 | -$6.60M derived: sum of 4 quarters · filed 2024-02-14 | |||
| 2022-03-31 | $101.90M 10-Q · filed 2023-04-25 | $72.20M derived: sum of 2 quarters · filed 2024-02-14 | $161.20M derived: sum of 3 quarters · filed 2024-02-14 | $267.90M derived: sum of 4 quarters · filed 2024-02-14 | |||
| 2021-12-31 | -$29.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $59.30M derived: sum of 2 quarters · filed 2024-02-14 | $166.00M derived: sum of 3 quarters · filed 2024-02-14 | $230.80M 10-K · filed 2024-02-14 | |||
| 2021-09-30 | $89.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-25 | $195.70M derived: sum of 2 quarters · filed 2022-10-25 | $260.50M 10-Q · filed 2022-10-25 | $177.70M derived: sum of 4 quarters · filed 2023-02-15 | |||
| 2021-06-30 | $106.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-20 | $171.50M 10-Q · filed 2022-07-20 | $88.70M derived: sum of 3 quarters · filed 2023-02-15 | -$400.60M derived: sum of 4 quarters · filed 2023-02-15 | |||
| 2021-03-31 | $64.80M 10-Q · filed 2022-05-03 | -$18.00M derived: sum of 2 quarters · filed 2023-02-15 | -$507.30M derived: sum of 3 quarters · filed 2023-02-15 | -$225.70M derived: sum of 4 quarters · filed 2023-02-15 | |||
| 2020-12-31 | -$82.80M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | -$572.10M derived: sum of 2 quarters · filed 2023-02-15 | -$290.50M derived: sum of 3 quarters · filed 2023-02-15 | -$67.50M 10-K · filed 2023-02-15 | |||
| 2020-09-30 | -$489.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-20 | -$207.70M derived: sum of 2 quarters · filed 2021-10-20 | $15.30M 10-Q · filed 2021-10-20 | -$33.20M derived: sum of 4 quarters · filed 2022-02-03 | |||
| 2020-06-30 | $281.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-22 | $504.60M 10-Q · filed 2021-07-22 | $456.10M derived: sum of 3 quarters · filed 2022-02-03 | $213.80M derived: sum of 4 quarters · filed 2022-02-03 | |||
| 2020-03-31 | $223.00M 10-Q · filed 2021-04-22 | $174.50M derived: sum of 2 quarters · filed 2022-02-03 | -$67.80M derived: sum of 3 quarters · filed 2022-02-03 | $68.80M derived: sum of 4 quarters · filed 2022-02-03 | |||
| 2019-12-31 | -$48.50M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-03 | -$290.80M derived: sum of 2 quarters · filed 2022-02-03 | -$154.20M derived: sum of 3 quarters · filed 2022-02-03 | $16.10M 10-K · filed 2022-02-03 | |||
| 2019-09-30 | -$242.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-21 | -$105.70M derived: sum of 2 quarters · filed 2020-10-21 | $64.60M 10-Q · filed 2020-10-21 | $70.70M derived: sum of 4 quarters · filed 2021-02-03 | |||
| 2019-06-30 | $136.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-22 | $306.90M 10-Q · filed 2020-07-22 | $313.00M derived: sum of 3 quarters · filed 2021-02-03 | $445.20M derived: sum of 4 quarters · filed 2021-02-03 | |||
| 2019-03-31 | $170.30M 10-Q · filed 2020-04-23 | $176.40M derived: sum of 2 quarters · filed 2021-02-03 | $308.60M derived: sum of 3 quarters · filed 2021-02-03 | $234.40M derived: sum of 4 quarters · filed 2021-02-03 | |||
| 2018-12-31 | $6.10M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-03 | $138.30M derived: sum of 2 quarters · filed 2021-02-03 | $64.10M derived: sum of 3 quarters · filed 2021-02-03 | $321.70M 10-K · filed 2021-02-03 | |||
| 2018-09-30 | $132.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-22 | $58.00M derived: sum of 2 quarters · filed 2019-10-22 | $315.60M 10-Q · filed 2019-10-22 | $1.45B derived: sum of 4 quarters · filed 2020-02-06 | |||
| 2018-06-30 | -$74.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | $183.40M 10-Q · filed 2019-07-24 | $1.32B derived: sum of 3 quarters · filed 2020-02-06 | $1.60B derived: sum of 4 quarters · filed 2020-02-06 | |||
| 2018-03-31 | $257.60M 10-Q · filed 2019-04-24 | $1.39B derived: sum of 2 quarters · filed 2020-02-06 | $1.68B derived: sum of 3 quarters · filed 2020-02-06 | $1.76B derived: sum of 4 quarters · filed 2020-02-06 | |||
| 2017-12-31 | $1.13B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-06 | $1.42B derived: sum of 2 quarters · filed 2020-02-06 | $1.50B derived: sum of 3 quarters · filed 2020-02-06 | $1.30B 10-K · filed 2020-02-06 | |||
| 2017-09-30 | $285.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-23 | $365.60M derived: sum of 2 quarters · filed 2018-10-23 | $170.50M 10-Q · filed 2018-10-23 | $85.30M derived: sum of 4 quarters · filed 2019-02-06 | |||
| 2017-06-30 | $80.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-24 | -$114.70M 10-Q · filed 2018-07-24 | -$199.90M derived: sum of 3 quarters · filed 2019-02-06 | -$270.60M derived: sum of 4 quarters · filed 2019-02-06 | |||
| 2017-03-31 | -$195.10M 10-Q · filed 2018-04-24 | -$280.30M derived: sum of 2 quarters · filed 2019-02-06 | -$351.00M derived: sum of 3 quarters · filed 2019-02-06 | -$704.50M derived: sum of 4 quarters · filed 2019-02-06 | |||
| 2016-12-31 | -$85.20M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-06 | -$155.90M derived: sum of 2 quarters · filed 2019-02-06 | -$509.40M derived: sum of 3 quarters · filed 2019-02-06 | -$232.60M 10-K · filed 2019-02-06 | |||
| 2016-09-30 | -$70.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-24 | -$424.20M derived: sum of 2 quarters · filed 2017-10-24 | -$147.40M 10-Q · filed 2017-10-24 | -$575.60M derived: sum of 4 quarters · filed 2018-02-01 | |||
| 2016-06-30 | -$353.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-25 | -$76.70M 10-Q · filed 2017-07-25 | -$151.70M 10-Q · filed 2016-07-21 | -$504.90M derived: sum of 3 quarters · filed 2018-02-01 | -$608.10M derived: sum of 4 quarters · filed 2018-02-01 | ||
| 2016-03-31 | $276.80M 10-Q · filed 2017-04-25 | $225.10M 10-Q · filed 2016-04-21 | -$151.40M derived: sum of 2 quarters · filed 2018-02-01 | -$254.60M derived: sum of 3 quarters · filed 2018-02-01 | -$306.60M derived: sum of 4 quarters · filed 2018-02-01 | ||
| 2015-12-31 | -$428.20M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-01 | -$531.40M derived: sum of 2 quarters · filed 2018-02-01 | -$583.40M derived: sum of 3 quarters · filed 2018-02-01 | -$429.40M 10-K · filed 2018-02-01 | -$410.20M 10-K · filed 2016-02-03 | ||
| 2015-09-30 | -$103.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-26 | -$155.20M derived: sum of 2 quarters · filed 2016-10-26 | -$1.20M 10-Q · filed 2016-10-26 | ||||
| 2015-06-30 | -$52.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-21 | $102.00M 10-Q · filed 2016-07-21 | $102.02M 10-Q · filed 2015-07-24 | ||||
| 2015-03-31 | $154.00M 10-Q · filed 2016-04-21 | $154.02M 10-Q · filed 2015-04-24 | |||||
| 2014-12-31 | $40.30M 10-K · filed 2017-02-02 | $61.00M 10-K · filed 2016-02-03 | |||||
| 2014-06-30 | $49.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-24 | $31.11M 10-Q · filed 2015-07-24 | |||||
| 2014-03-31 | -$18.64M 10-Q · filed 2015-04-24 | ||||||
| 2013-12-31 | $156.80M 10-K · filed 2016-02-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |